The nuclear factor κB subunits RelA/p65 and c-Rel potentiate but are not required for Ras-induced cellular transformation

被引:46
作者
Hanson, JL
Hawke, NA
Kashatus, D
Baldwin, AS
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA
关键词
D O I
10.1158/0008-5472.CAN-03-3898
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Extensive data indicate that oncoproteins, such as oncogenic H-Ras, initiate signal transduction cascades that ultimately lead to the activation of specific transcription factors. We and others have previously demonstrated that Ras activates the inherent transcriptional activation function of the transcription factor nuclear factor kappaB (NF-kappaB). Supportive of the importance of NF-kappaB in transformation, Ras-induced cellular transformation can be suppressed by expression of IkappaBalpha, an inhibitor of NF-kappaB, or by dominant-negative forms of the upstream activator IkappaB kinase (IKK). However, conclusive evidence for a requirement for NF-kappaB subunits in oncogenic transformation has not been reported. Furthermore, there is little understanding of the gene targets controlled by NF-kappaB that might support oncogenic conversion. The data presented here demonstrate that, although both p65 and c-Rel enhance the frequency of Ras-induced cellular transformation, these NF-kappaB subunits are not essential for Ras to transform spontaneously immortalized murine fibroblasts. Microarray analysis identified a set of genes induced by Ras that is dependent on NF-kappaB for their expression and that likely play contributory roles in promoting Ras-induced oncogenic transformation.
引用
收藏
页码:7248 / 7255
页数:8
相关论文
共 44 条
[1]   Role of the IκB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells [J].
Arsura, M ;
Mercurio, F ;
Oliver, AL ;
Thorgeirsson, SS ;
Sonenshein, GE .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (15) :5381-5391
[2]   Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB [J].
Baldwin, AS .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 107 (03) :241-246
[3]  
BOS JL, 1989, CANCER RES, V49, P4682
[4]  
Chadeneau C, 1996, INT J CANCER, V68, P817
[5]  
COHEN RL, 1989, J BIOL CHEM, V264, P8375
[6]   PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 INHIBITS TUMOR-NECROSIS-FACTOR-ALPHA-INDUCED APOPTOSIS - EVIDENCE FOR AN ALTERNATE BIOLOGICAL FUNCTION [J].
DICKINSON, JL ;
BATES, EJ ;
FERRANTE, A ;
ANTALIS, TM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27894-27904
[7]   Polo-like kinase1, a new target for antisense tumor therapy [J].
Elez, R ;
Piiper, A ;
Giannini, CD ;
Brendel, M ;
Zeuzem, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 269 (02) :352-356
[8]   Oncogenic Ha-Ras-induced signaling activates NF-kappa B transcriptional activity, which is required for cellular transformation [J].
Finco, TS ;
Westwick, JK ;
Norris, JL ;
Beg, AA ;
Der, CJ ;
Baldwin, AS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (39) :24113-24116
[9]   Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-κB have a malignantly transformed phenotype [J].
Gapuzan, MER ;
Yufit, PV ;
Gilmore, TD .
ONCOGENE, 2002, 21 (16) :2484-2492
[10]   Missing pieces in the NF-κB puzzle [J].
Ghosh, S ;
Karin, M .
CELL, 2002, 109 :S81-S96